CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing ...

Learn more about whether Aurinia Pharmaceuticals Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ ...

Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...

India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...

Launching the therapy, Dr. Jitendra Singh declared that India has officially begun its decisive march toward a Sickle ...

In a major leap for Atmanirbhar Bharat and India’s genomic medicine capabilities, the government on Wednesday launched the ...

ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...

A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

CRISPR has turned a simple fungus into a fast-growing, meat-like protein source with impressively low environmental impact.

CSIR-IGIB and Serum Institute of India sign a tech transfer pact to develop an indigenous, affordable CRISPR-based ...

Setting a new milestone in Atmanirbhar Bharat, the government on Wednesday launched an indigenous CRISPR-based gene therapy ...

Indian scientists have created a cost-effective, indigenous gene editing technology to aid commercial genome-edited crop breeding.